CoChat

Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade

Open access
Lue, Hui-wen, Podolak, Jennifer, Kolahi, Kevin, Cheng, Larry, Rao, Soumya, Garg, Devin, Xue, Chang-Hui, Rantala, Juha K., Tyner, Jeffrey W., Thornburg, Kent L., Martinez-Acevedo, Ann, Liu, Jen-Jane, Amling, Christopher L., Truillet, Charles, Louie, Sharon M., Anderson, Kimberly E., Evans, Michael J., O'Donnell, Valerie B., Nomura, Daniel K., Drake, Justin M., Ritz, Anna, Thomas, George V. · 2017 · Genes & Development
Cited by 89

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

There is limited knowledge about the metabolic reprogramming induced by cancer therapies and how this contributes to therapeutic resistance. Here we show that although inhibition of PI3K–AKT–mTOR signaling markedly decreased glycolysis and restrained tumor growth, these signaling and metabolic restrictions triggered autophagy, which supplied the metabolites required for the maintenance of mitochondrial respiration and redox homeostasis. Specifically, we found that survival of cancer cells was critically dependent on phospholipase A2 (PLA2) to mobilize lysophospholipids and free fatty acids to sustain fatty acid oxidation and oxidative phosphorylation. Consistent with this, we observed significantly increased lipid droplets, with subsequent mobilization to mitochondria. These changes were abrogated in cells deficient for the essential autophagy gene ATG5. Accordingly, inhibition of PLA2 significantly decreased lipid droplets, decreased oxidative phosphorylation, and increased apoptosis. Together, these results describe how treatment-induced autophagy provides nutrients for cancer cell survival and identifies novel cotreatment strategies to override this survival advantage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.305292.117

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 89

Metadata

Authors
Lue, H.-W., Podolak, J., Kolahi, K., Cheng, L., Rao, S., Garg, D., Xue, C.-H., Rantala, J. K., Tyner, J. W., Thornburg, K. L., Martinez-Acevedo, A., Liu, J.-J., Amling, C. L., Truillet, C., Louie, S. M., Anderson, K. E., Evans, M. J., O'Donnell, V. B., Nomura, D. K., Drake, J. M., Ritz, A., & Thomas, G. V.
Venue
Genes & Development
Published
2017-10-15
Volume
31
Issue
20
Pages
2067-2084
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2767761043
Cited by
89
References
19
Type
posted content
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade. https://app.cochat.ai/papers/10.1101/gad.305292.117
The paper
Lue, H.-W., Podolak, J., Kolahi, K., Cheng, L., Rao, S., Garg, D., Xue, C.-H., Rantala, J. K., Tyner, J. W., Thornburg, K. L., Martinez-Acevedo, A., Liu, J.-J., Amling, C. L., Truillet, C., Louie, S. M., Anderson, K. E., Evans, M. J., O'Donnell, V. B., Nomura, D. K., . . . Thomas, G. V. (2017). Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade. Genes & Development. https://doi.org/10.1101/gad.305292.117

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.